Inventor

JACKOWSKI GEORGE

CA73 patents

⚠️ This page may combine multiple inventors who share the name “JACKOWSKI GEORGE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

JACKOWSKI GEORGE

SYN X PHARMA INC

Biopolymer marker indicative of disease state having a molecular weight of 1350 daltons

IG heavy chain, IG kappa, IG lambda biopolymer markers predictive of Alzheimer&#39;s disease

Biopolymer marker indicative of disease state having a molecular weight of 1465 daltons

Biopolymer marker indicative of disease state having molecular weight of 2937 daltons

Biopolymer marker indicative of disease state having a molecular weight of 1865 daltons

Biopolymer marker indicative of disease state having a molecular weight of 1449 daltons

Process for differential diagnosis of Alzheimer&#39;s dementia and device therefor

Biopolymer marker indicative of disease state having a molecular weight of 2021 daltons

Biopolymer marker indicative of disease state having a molecular weight of 1206 daltons

Biopolymer marker indicative of disease state having a molecular weight of 2267 daltons

Biopolymer marker indicative of disease state having a molecular weight of 1020 daltons

Biopolymer marker indicative of disease state having a molecular weight of 1690 daltons

Betaine/GABA transport protein biopolymer marker indicative of insulin resistance

Protein biopolymer markers predictive of insulin resistance

Inter-alpha trypsin inhibitor biopolymer marker indicative of insulin resistance

Biopolymer marker indicative of disease state having a molecular weight of 1845 daltons

Process for determining the presence of monomeric brain associated human glutamine synthetase in patients exhibiting mild cognitive impairment

Fibronectin biopolymer marker indicative of insulin resistance

Biopolymer marker indicative of disease state having a molecular weight of 1211 daltons

Method for detecting the presence of monomeric brain associated human glutamine synthetase

Method for retarding or precluding Alzheimer&#39;s dementia

SPECTRAL DIAGNOSTICS INC

Method and device for diagnosing and distinguishing chest pain in early onset thereof

Method and device for diagnosing and distinguishing chest pain in early onset thereof

Diagnostic kit for diagnosing and distinguishing chest pain in early onset thereof

Method and device for diagnosing and distinguishing chest pain in early onset thereof

Method and device for diagnosing and distinguishing chest pain in early onset thereof

Monoclonal antibody to human cardiac myoglobin

Purified cardiac troponin I

Method for purification of cardiac troponin I

NANOGEN INC

Polyclonal-monoclonal ELISA assay for detecting N-terminus proBNP

Conjunctive analysis of biological marker expression for predicting cardiac mortality

Biopolymer marker indicative of disease state having a molecular weight of 1562 daltons

Method for diagnosing and distinguishing stroke and diagnostic devices for use therein

Interalpha trypsin inhibitor biopolymer markers indicative of insulin resistance

Protein biopolymer markers indicative of insulin resistance

Biopolymer marker indicative of disease state having a molecular weight of 1348 daltons

SYN X PHARMA

Method for diagnosing and distinguishing stroke and diagnostic devices for use therein

Conjunctive analysis of biological marker expression for diagnosing organ failure

Method for diagnosing and distinguishing stroke and diagnostic devices for use therein

Biopolymer marker indicative of disease state having a molecular weight of 1097 daltons

PRINCETON BIOMEDITECH CORP

Immunoassay device for diagnosing congestive heart failure and predicting mortality in congestive heart failure patients

Immunossay device for diagnosing congestive heart failure and predicting mortality in congestive heart failure patients

Immunoassay device for diagnosing congestive heart failure and predicting mortality in congestive heart failure patients

NEXUS DX INC

Polyclonal-monoclonal ELISA assay for detecting N-terminus pro-BNP

Method for diagnosing and distinguishing stroke and diagnostic devices for use therein

JACKOWSKI GEORGE

Omega 3 fatty acid for use as a prescription medical food and omega 3 fatty acid diagniostic assay for the dietary management of cardiovascular patients with cardiovascular disease (CVD) who are deficient in blood EPA and DHA levels

Method for treating obesity with anti-obesity formulations and omega 3 fatty acids for the reduction of body weight in cardiovascular disease patients (CVD) and diabetics

SPECTRAL DIAGNOSTICS

Monoclonal antibody to human ventricular myosin light chains

(unassigned)

Biopolymer marker indicative of disease state having a molecular weight of 1,896 daltons

TOXIN ALERT INC

Method and apparatus for detection of multiple biological materials with a heterogeneous antibody mixture

IG heavy chain, IG kappa, IG lambda biopolymer markers predictive of Alzheimer's disease

Process for differential diagnosis of Alzheimer's dementia and device therefor

Method for retarding or precluding Alzheimer's dementia